New Report on Small-Molecule Targeted Cancer Therapies by Visiongain

06 Feb 2012 • by Natalie Aster

Revenue predictions at overall world market, product and national levels to 2021, trends and opportunities in that market are featured in the new Visiongain's report “Small-Molecule Targeted Cancer Therapies: World Market 2011-2021”.

New study discusses personalised medicine and other developments, as well as competition. Find out how events this decade will affect the industry and market for anti-cancer drugs.

This report provides data, analysis and opinion to benefit any research, calculations, meetings and presentations.

Report Details:

Small-Molecule Targeted Cancer Therapies: World Market 2011-2021
Published: December, 2011
Pages: 170
Price: US$ 2.642,00

More information can be found in the report “Small-Molecule Targeted Cancer Therapies: World Market 2011-2021” by Visiongain.

To order the report or ask for sample pages contact [email protected]

Contacts

MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]
MarketPublishers.com